KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Non Operating Investment Income (2016 - 2025)

Opko Health (OPK) has disclosed Non Operating Investment Income for 16 consecutive years, with -$134000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Investment Income changed N/A year-over-year to -$134000.0, compared with a TTM value of -$429000.0 through Dec 2025, up 98.36%, and an annual FY2025 reading of -$429000.0, up 98.36% over the prior year.
  • Non Operating Investment Income was -$134000.0 for Q4 2025 at Opko Health, down from -$38000.0 in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $1.3 million in Q3 2021 and bottomed at -$26.2 million in Q1 2024.
  • Average Non Operating Investment Income over 5 years is -$1.4 million, with a median of -$1000.0 recorded in 2024.
  • The sharpest move saw Non Operating Investment Income skyrocketed 1700.0% in 2023, then plummeted 3700.0% in 2025.
  • Year by year, Non Operating Investment Income stood at $275000.0 in 2021, then tumbled by 101.09% to -$3000.0 in 2022, then surged by 1700.0% to $48000.0 in 2023, then tumbled by 102.08% to -$1000.0 in 2024, then crashed by 13300.0% to -$134000.0 in 2025.
  • Business Quant data shows Non Operating Investment Income for OPK at -$134000.0 in Q4 2025, -$38000.0 in Q3 2025, and $16000.0 in Q2 2025.